Trials / Completed
CompletedNCT05003882
Radicle ACES: A Study of Commercially Available CBD Used in the Real-world Setting
A Randomized, Open-label Study of Commercially Available, Orally Ingestible, Cannabidiol (CBD) Products Used in the Real-world Setting for Pain, Sleep, and Anxiety
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (actual)
- Sponsor
- Radicle Science · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-label study of commercially available, orally ingestible, Cannabidiol (CBD) products used in the real-world setting for pain, sleep, and anxiety.
Detailed description
Radicle ACES is a real-world evidence study that aims to determine the effect of CBD on overall well-being, anxiety, sleep, and pain over a 28-day period in treatment groups compared to a waitlist control group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Commercially available, orally ingestible CBD product | botanically-derived CBD extract product |
Timeline
- Start date
- 2021-08-02
- Primary completion
- 2021-10-30
- Completion
- 2021-12-31
- First posted
- 2021-08-13
- Last updated
- 2022-03-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05003882. Inclusion in this directory is not an endorsement.